The world’s first pill to treat COVID-19 set for approval
Merck and Merck and Ridgeback Biotherapeutics today announced that the submission of an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administration (FDA) for molnupiravir, an investigational ...